Ikaria

Manufacturing · New Jersey, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

22 Worlds Fair Dr Ste J, Somerset, New J...

Phone Number

(732) 356-8082

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development Medical Devices & Equipment
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1

About Ikaria

Ikaria, Inc. is a critical care company focused on developing and commercializing innovative therapies (drugs and devices) designed to address the significant needs of critically ill patients. The companys lead product is INOMAX® (nitric oxide) for inhalation, the only FDA-approved drug for the treatment of hypoxic respiratory failure associated with pulmonary hypertension in term and near-term infants. It is offered through the INOMAX therapy package, an all-inclusive offering of drug product, drug-delivery system, on-site training and 24/7/365 technical assistance and support. The INOMAX therapy package is marketed in the USA, Puerto Rico, Canada, Australia, Mexico and JapanExplore more
Ikaria's Social MediaPopular SearchesIkariaikaria IncIkaria Holdings IncIkarIkaria HoldingsSIC Code 28,283NAICS Code 32,325Show more

Ikaria Org Chart

PhoneEmail
SK
United States flag for contact location.

Vice President, Global Regulatory Affairs

PhoneEmail
JB
United States flag for contact location.

Vice President, Clinical Resaerch

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
JH
United States flag for contact location.

Director, Contracts & Outsoucing

PhoneEmail
JJ
United States flag for contact location.

Director, Quality Assurance Compliance

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Ikaria your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Ikaria

Compare insights from companies similar to Ikaria, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Ikaria

<$5M
51-200
Private
-
2006
SK
Steven KnappVice President, Global Regulatory Affairs
$10.6M
11-50
Public
$100.2M
2009
Gerald Proehl, President & Chief Executive Officer at Tenax Therapeutics
Gerald ProehlPresident & CEO
$7.3M
51-200
Private
$200.3M
2016
DS
Daniel SmitheyPresident, CEO & Founder
$6.3M
11-50
Private
<$5M
2007
PB
Pamela BaxterDirector, Quality
<$5M
11-50
Private
-
2004
N/A
<$5M
11-50
Private
<$5M
2000
ES
Eli SulkinFounder, President & CEO
<$5M
11-50
Private
-
1995
AF
Andrew FosterExecutive Vice President
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Ikaria is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Ikaria is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ikaria.

Top Manufacturing Companies

Frequently Asked Questions Regarding Ikaria

What is Ikaria's official website?
Ikaria's official website is www.ikaria.com
What is Ikaria's Revenue?
Ikaria's revenue is <$5 Million
What is Ikaria's SIC code?
Ikaria's SIC: 28,283
What is Ikaria's NAICS code?
Ikaria's NAICS: 32,325
How many employees does Ikaria have?
Ikaria has 51-200 employees
What industry does Ikaria belong to?
Ikaria is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Ikaria competition?
Ikaria top competitors include: Tenax Therapeutics, Serán, PharmaIN, Velesco Pharmaceutical Services
What companies has Ikaria acquired?
Ikaria has acquired the companies: IKARIA, Inc - now a part of Mallinckrodt Pharmaceuticals, Questcor Pharmaceuticals, Mallinckrodt Hospital Products, Mallinckrodt Pharmaceuticals
How do I contact Ikaria?
Ikaria contact info: Phone number: (732) 356-8082 Website: www.ikaria.com
What does Ikaria do?

Ikaria, Inc. is a critical care company focused on developing and commercializing innovative therapies (drugs and devices) designed to address the significant needs of critically ill patients. The companys lead product is INOMAX® (nitric oxide) for inhalation, the only FDA-approved drug for the treatment of hypoxic respiratory failure associated wi... th pulmonary hypertension in term and near-term infants. It is offered through the INOMAX therapy package, an all-inclusive offering of drug product, drug-delivery system, on-site training and 24/7/365 technical assistance and support. The INOMAX therapy package is marketed in the USA, Puerto Rico, Canada, Australia, Mexico and JapanRead More

What are Ikaria social media links?
Ikaria Linkedin page
Is Ikaria a public company?
Ikaria is private company therefore does not currently have an official ticker symbol
See more information about Ikaria

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.